The University of Chicago Header Logo

Connection

S. Margaret Paik to Tamoxifen

Back to Details
This is a "connection" page, showing publications S. Margaret Paik has written about Tamoxifen.
S. Margaret Paik
Connection Strength
0.034
Tamoxifen
  1. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019 01; 20(1):88-99.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.